Avadel Pharmaceuticals PLC (AVDL)
15.49
-0.45
(-2.82%)
USD |
NASDAQ |
May 17, 16:00
15.26
-0.23
(-1.48%)
After-Hours: 20:00
Avadel Pharmaceuticals Free Cash Flow (Quarterly): -29.70M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -29.70M |
| December 31, 2023 | -28.03M |
| September 30, 2023 | -38.23M |
| June 30, 2023 | -32.02M |
| March 31, 2023 | -30.23M |
| December 31, 2022 | -15.37M |
| September 30, 2022 | -7.519M |
| June 30, 2022 | -14.09M |
| March 31, 2022 | -34.04M |
| December 31, 2021 | -22.51M |
| September 30, 2021 | -21.24M |
| June 30, 2021 | -10.15M |
| March 31, 2021 | -23.44M |
| December 31, 2020 | -19.19M |
| September 30, 2020 | -10.22M |
| June 30, 2020 | -7.781M |
| March 31, 2020 | -11.64M |
| December 31, 2019 | -8.253M |
| September 30, 2019 | -7.419M |
| June 30, 2019 | -1.446M |
| March 31, 2019 | -21.24M |
| December 31, 2018 | -24.54M |
| September 30, 2018 | -20.32M |
| June 30, 2018 | -39.99M |
| March 31, 2018 | -18.05M |
| Date | Value |
|---|---|
| December 31, 2017 | -14.85M |
| September 30, 2017 | -55.41M |
| June 30, 2017 | 8.241M |
| March 31, 2017 | 24.97M |
| December 31, 2016 | 7.54M |
| September 30, 2016 | -5.001M |
| June 30, 2016 | -4.748M |
| March 31, 2016 | 19.91M |
| December 31, 2015 | 25.85M |
| September 30, 2015 | 18.18M |
| June 30, 2015 | 13.60M |
| March 31, 2015 | 25.04M |
| December 31, 2014 | -6.635M |
| September 30, 2014 | 2.805M |
| June 30, 2014 | -5.718M |
| March 31, 2014 | -2.797M |
| December 31, 2013 | -7.281M |
| September 30, 2013 | -0.447M |
| June 30, 2013 | -5.957M |
| March 31, 2013 | -8.02M |
| December 31, 2012 | -6.484M |
| September 30, 2012 | -5.939M |
| June 30, 2012 | -6.864M |
| March 31, 2012 | -4.921M |
| December 31, 2011 | -4.04M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-38.23M
Minimum
Sep 2023
-1.446M
Maximum
Jun 2019
-18.63M
Average
-17.28M
Median
Free Cash Flow (Quarterly) Benchmarks
| Trinity Biotech PLC | -0.649M |
| Amarin Corp PLC | -12.60M |
| DBV Technologies SA | -36.03M |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | -- |